Surgical Management of Primary Mediastinal Germ Cell TumorsPatient SelectionAny anterior mediastinal mass (Figures 1, 2) must be considered suspect for germ cell tumor, especially in a young male. Errors in diagnosis are not uncommon and can result in mismanagement of a potentially curable patient. All patients with an anterior mediastinal mass should have alpha-fetoprotein (AFP), β-human chorionic gonadotropin (β-HCG), and lactate dehydrogenase (LDH) levels drawn at the outset. The different types of germ cell histologies are shown in Figure 3. A number of hematologic malignancies may occur in conjunction with mediastinal non-seminomatous germ cell tumors (NSGCT), such as acute megakaryocytic leukemia, myelodysplastic syndrome, refractory thrombocytopenia, refractory anemia with excess blasts, malignant histiocytosis, and systemic mastocytosis. In approximately 80% of nonseminomatous germ cell tumors, AFP is elevated. β-HCG is elevated in approximately 30% to 35% of patients and may lead to gynecomastia in a young male patient. Either tumor marker may be elevated alone or together in any particular patient [1, 2]. The presence of any nonseminomatous element (i.e. elevated AFP), even in a tumor that is predominantly seminomatous by histology, is classified as a nonseminomatous germ cell tumor and treated as such. Patients with pure seminomas should never have an elevated serum AFP; its presence implies the presence of yolk sac tumor and embryonal cell carcinoma in the primary or in a metastatic site. In mature teratomas, AFP, B-HCG and LDH are normal. Although treatment can be initiated based upon positive tumor marker results, histological diagnosis is recommended. There is a pathologic discrepancy of 6% between histology and fine-needle aspiration (FNA), and difficulty may arise in differentiating germ cell tumor from poorly differentiated carcinoma [3]. Core needle biopsy should be performed when possible and, if surgical biopsy is warranted, an anterior mediastinotomy (Chamberlain) is usually the procedure of choice. In diagnostic dilemmas, tissue should be sent for genetic analysis - specifically the i(12p) chromosomal abnormality, which is a consistent finding in germ cell tumors and rarely observed in other tumors. Chemotherapy is the mainstay of initial treatment and surgery should be viewed as an adjuvant to chemotherapy. Bleomycin, etoposide, and cisplatin (BEP) is the current standard [4, 5]. A rapid decline of tumor marker levels with platin-based chemotherapy treatment is associated with improved response rates and overall survival [6]. Chemotherapy is also indicated post-surgical resection when viable tumor is present in the resected specimen. After initial treatment with chemotherapy, a patient with tumor marker normalization and a persistent mass on computed tomography is the most favorable candidate for surgical resection. Patients demonstrating a residual mass on computed tomography and persistently elevated tumor markers have been treated with salvage chemotherapy in the past in an effort to obtain normal tumor marker levels prior to surgery. This approach, however, has not improved outcome [5], and currently our practice is to recommend surgery after initial chemotherapy (regardless of persistently elevated tumor markers) in an attempt to achieve complete surgical resection. If patients are to undergo salvage chemotherapy preoperatively, this should be performed in a clinical trial setting. In rare circumstances, post-chemotherapy patients will demonstrate normalized tumor marker levels but no residual mass on computed tomography. Surgery is not recommended in these patients. Instead, they should be followed by serial computed tomography scans. Operative StepsSurgical assessment should be obtained prior to chemotherapy as well as after treatment. Attention to the patient’s functional status, hematologic function, and pulmonary function testing [especially the diffusion capacity (DLCO)] is critical. Post-chemotherapy DLCO measurement is essential because of the potential of bleomycin toxicity leading to progressive pulmonary fibrosis. If major anatomic lung resection is anticipated (based upon the pretreatment computed tomography), then the amount of bleomycin administered should be limited. The procedure is performed with a double lumen endotracheal tube in place. Lung collapse is frequently required in order to facilitate exposure and/or lung resection. FiO2 should be kept to a minimum because of the potential harmful effects after neoadjuvant treatment with bleomycin. If there is any possibility of resection of the superior vena cava (SVC), femoral venous access should be obtained. Incisions Median Sternotomy Hemiclamshell Thoracotomy Hemiclamshell Thoracotomy with neck extension
Hemiclamshell Thoracotomy with transverse supraclavicular extension (trap door) Clamshell Posterolateral Thoracotomy Intraoperative decision making: To resect or not to resect?Neoadjuvant chemotherapy is very effective in treating mediastinal germ cell tumors. However, the residual mass becomes intimate with surrounding structures and frequently there are no discernible tissue planes. In these cases, the surgeon is faced with the decision whether or not to resect major structures, with the attendant morbidity versus potentially leaving residual tumor in the chest. Although tissue planes are distorted, one may be able to peel the mass off from structures such as the SVC and phrenic nerve. Some surgeons have recommended shaving a piece of tissue from multiple areas for frozen section analysis. If only fibrosis is evident, then peeling the mass off adjacent structures is reasonable; if it shows tumor, then en-bloc resection is performed. However, many lesions are mixed with necrotic and viable components and may contain seminomatous and non-seminomatous germ cell tumor, teratoma, carcinomatous and sarcomatous elements. Because of this, biopsy of certain areas may not be representative of the entire specimen. Since this method of biopsy is not always accurate, if invasion is suspected intraoperatively, then we recommend resection of technically resectable structures. Our data showed residual viable tumor in 66% of cases [7]. Therefore, we have a low threshold for resecting phrenic nerve, lung, SVC, pericardium, etc., en-bloc. Dissection is usually started from left to right since the structures on the left are usually considered unresectable (e.g. aorta) and the structures on the right are considered resectable (e.g. SVC). This will allow an assessment as to whether complete resection is possible. If so, a more radical procedure is reasonable. Should the complete removal of all disease not be possible, then the resection of major structures such as the SVC or phrenic nerve may be futile and not worth the attendant morbidity. When tumor markers have completely normalized, fibrosis will usually be encountered at the periphery. Conversely, when tumor markers persist, it is likely that viable tumor is present. However, there is no steadfast rule in making the decision to resect or not to resect a major structure. Resectable structuresThymus Pericardium Lung Very large tumors can compress the lung to the size of a fist and may deceivingly appear to require a pneumonectomy. Once the mediastinal portion is completely mobilized, positive pressure ventilation is applied to the affected lung with the tumor lifted up and off the mainstem bronchus. This maneuver helps to identify the plane of dissection between lung and tumor. Phrenic nerve Innominate Veins Superior Vena Cava SVC resection may be performed as demonstrated by Venuta et al., in a previous thoracic expert technique section [8]. In situations where the SVC is completely resected, the right phrenic nerve usually requires resection as well. Postoperative Management Post-pericardiotomy syndrome may occur after resection. Symptoms and clinical findings include pain at the tip of the scapula, fever, pericardial effusion, and diffuse ST elevations on EKG. Treatment with Ibuprofen or NSAIDS generally results in improvement. Preference Card
Tips & Pitfalls
ResultsWe recently published our series from Memorial Sloan-Kettering of 32 patients who underwent post-chemotherapy surgical resection of mediastinal germ cell tumors [7]. Histologic analysis revealed viable tumor in 66%, teratoma in 22%, and necrosis in 12% of the specimens. Viable tumor included embryonal carcinoma, choriocarcinoma, yolk sac carcinoma, seminoma, and teratoma with malignant transformation to non-germ cell histology (e.g. sarcoma). Since teratoma and residual tumor were found in the majority of resected patients, we maintain an aggressive approach to surgical resection of potentially involved adjacent structures. The Kaplan Meier curve showing the survival of the 32 patients who underwent post-chemotherapy surgery is shown in Figure 12. References
Publication Date: 23-Mar-2004 |
©2010 CTSNet